Vera Therapeutics Inc. (VERA)
32.29
-1.09 (3.27%)
Upcoming Events
Latest Headlines
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026 4:05 PM - StreetInsider
Jefferies Reiterates Buy Rating on Vera Therapeutics (VERA)
June 2, 2026 3:56 PM - StreetInsider
William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
June 2, 2026 2:02 PM - StreetInsider
Wolfe Research: 'VERA's continued weakness is creating a favorable setup into the July 7th PDUFA'
June 2, 2026 12:28 PM - StreetInsider
Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update'
June 2, 2026 11:15 AM - StreetInsider
Raymond James: ''If Vera is successful with this new plan, it could effectively shorten the theoretical lead Otsuka'
June 2, 2026 10:12 AM - StreetInsider
TD Cowen on Vera Therapeutics (VERA): 'Launch prep remains on track; we have confidence in a clean approval'
June 2, 2026 7:16 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Jun 02
June 2, 2026 7:05 AM - SEC Filing
Vera Therapeutics moves up atacicept analysis timeline with FDA agreement
June 2, 2026 7:00 AM - StreetInsider
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
June 2, 2026 7:00 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: May 21
May 26, 2026 4:55 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Morrison Scott W
May 26, 2026 4:40 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Cheng Andrew
May 26, 2026 4:40 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: SEIDENBERG BETH C
May 26, 2026 4:39 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Oliger Christy J.
May 26, 2026 4:38 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Meyers James R
May 26, 2026 4:34 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Hall Kimball
May 26, 2026 4:32 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: MORRISSEY MICHAEL
May 26, 2026 4:30 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: ENRIGHT PATRICK G
May 26, 2026 4:27 PM - SEC Filing
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
May 15, 2026 10:09 AM - SEC Filing
Vera Therapeutics (VERA) PT Lowered to $91 at Evercore ISI
May 15, 2026 7:15 AM - StreetInsider
Form 4 Vera Therapeutics, Inc. For: May 12 Filed by: Fordyce Marshall
May 13, 2026 4:27 PM - SEC Filing
Form 144 Vera Therapeutics, Inc. Filed by: Fordyce Marshall
May 12, 2026 4:34 PM - SEC Filing
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026 4:05 PM - Globe NewsWire
Form 10-Q Vera Therapeutics, Inc. For: Mar 31
May 7, 2026 4:36 PM - SEC Filing
Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
May 7, 2026 7:32 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: May 07
May 7, 2026 7:30 AM - SEC Filing
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026 7:30 AM - Globe NewsWire
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference
May 4, 2026 7:30 AM - Globe NewsWire
Form 4 Vera Therapeutics, Inc. For: Apr 14 Filed by: Fordyce Marshall
April 15, 2026 4:58 PM - SEC Filing
Form 144 Vera Therapeutics, Inc. Filed by: Fordyce Marshall
April 14, 2026 4:34 PM - SEC Filing
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 10, 2026 4:30 PM - StreetInsider
Form ARS Vera Therapeutics, Inc. For: Dec 31
April 9, 2026 4:07 PM - SEC Filing
Form DEFA14A Vera Therapeutics, Inc.
April 9, 2026 4:06 PM - SEC Filing
Form DEF 14A Vera Therapeutics, Inc. For: May 21
April 9, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G Vera Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
April 1, 2026 5:32 PM - SEC Filing
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: VANGUARD GROUP INC
March 27, 2026 1:51 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: Mar 23 Filed by: Wright-Mitchell Jane
March 25, 2026 7:08 PM - SEC Filing
Form 3 Vera Therapeutics, Inc. For: Mar 23 Filed by: Wright-Mitchell Jane
March 25, 2026 7:07 PM - SEC Filing
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer
March 25, 2026 7:30 AM - StreetInsider
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
March 25, 2026 7:30 AM - StreetInsider
Form 4 Vera Therapeutics, Inc. For: Mar 13 Filed by: Young Joseph R
March 16, 2026 6:52 PM - SEC Filing
Form SCHEDULE 13G Vera Therapeutics, Inc. Filed by: Deep Track Capital, LP
March 11, 2026 4:06 PM - SEC Filing
Wolfe Research Upgrades Vera Therapeutics (VERA) to Outperform
March 10, 2026 5:36 PM - StreetInsider
Increasing unusual call option volume: VERA HIMX SCO SAVA BNO WEAT ZVRA PROP GRPN
March 10, 2026 10:53 AM - StreetInsider
BofA Securities Reiterates Buy Rating on Vera Therapeutics (VERA): Vertex data "appears to pose no real threat"
March 9, 2026 5:40 PM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Mar 05
March 9, 2026 5:02 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: Mar 05 Filed by: Hite Christopher
March 9, 2026 4:50 PM - SEC Filing
Form 3 Vera Therapeutics, Inc. For: Mar 05 Filed by: Hite Christopher
March 9, 2026 4:48 PM - SEC Filing
Full Article List
